Kaleorid (Potassium Chloride)

Potassium chloride dissociates into potassium and chloride ions after oral ingestion. The potassium ions are absorbed into the bloodstream, raising extracellular potassium concentration. This re‑establishes the electrochemical gradient essential for cellular excitability, muscle contraction, and proper cardiac electrical activity, thereby correcting the deficit seen in hypokalemia.

The appropriate dose of Kaleorid is individualized by the prescribing clinician based on the patient’s current serum potassium level, underlying cause of the deficiency, renal function, and concurrent medications. The prescriber calculates the amount needed to safely raise potassium to the target range and adjusts it as follow‑up labs become available.

Safety data for Kaleorid during pregnancy and lactation are limited. Potassium is essential for fetal development, but excess levels can be harmful. Clinicians should weigh potential benefits against risks and consider monitoring maternal serum potassium closely if use is deemed necessary.

To order Kaleorid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and required import documentation.

Kaleorid provides potassium chloride, the most common and bioavailable form of oral potassium replacement. Compared with potassium gluconate or citrate, chloride offers a straightforward ion balance and is widely used in clinical practice. Choice of formulation often depends on patient tolerance, required dose, and specific electrolyte considerations.

Kaleorid should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Kaleorid is taken orally, usually with a full glass of water. It can be administered with or without food, although taking it with meals may reduce gastrointestinal irritation. The exact administration schedule is determined by the prescriber based on the patient’s potassium needs.

The most serious risks include hyperkalemia, which can cause life‑threatening cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Patients should be monitored for signs of elevated potassium, such as muscle weakness, palpitations, or ECG changes, and seek immediate medical attention if they occur.

Kaleorid should be avoided in individuals with existing hyperkalemia, severe renal impairment that limits potassium excretion, or in patients taking other potassium‑increasing agents without close monitoring. It is also contraindicated in those with known hypersensitivity to potassium chloride.